ASH 2018 | CLL news from ASH 2018: ibrutinib strikes again!
VJHemOnc is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Stephan Stilgenbauer, MD, of the University of Ulm, Ulm, Germany, discusses the chronic lymphocytic leukemia (CLL) highlights at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.
Get great new content delivered to your inboxSign up